Tuesday, November 12, 2013

SIMPLY PRICELESS: GOOGLE'S GIFT TO ITS SOCIAL MEDIA PLATFORM USERS

SIMPLY PRICELESS:
GOOGLE’S GIFT TO ITS SOCIAL MEDIA PLATFORM USERS
Google is now offering a semi-personalized URL to users of its social media platform – Google+.
The advantage of this free privilege to the users is that whenever they publish an item on the internet they can add their personal URL and be immediately linked to their Google+ profile. 

This priceless gift ensures that the published item will be indexed immediately in Google’s search engine without having to resort to the arcane language of HTML5. 
For example all I have to do here and now is type the following URL:
www.google.com/+MandyLenderMasterAttractor
and this blog post is indexed.

Monday, November 12, 2012

STATINS MAY BE CANCER RETARDANTS


 

Cholesterol lowering agents known commonly as statins are used widely to reduce the incidence of atherosclerotic vascular heart disease.  The statins reduce the “bad cholesterol”, known as LDL-C and increase lightly the blood levels of the “good cholesterol’ HDL-C.  The first product Mevacor (lovastatin) was introduced in 1987.  Since then several much more effective statins were released for clinical use.  Known among them are simvastatin (Zocor), atorvastatin (Lipitor) and Rosuvastatin (Crestor).

In 2005 a scientific report appeared in the New England Journal of Medicine showing that use of a statin reduces colon cancer risk by 47 percent.  

About a year ago a study published in the Journal Cancer showed that men taking statins may be 30 percent less likely to experience a recurrence of prostatic cancer. 

Recently a new study was published in the New England Journal of Medicine (Nov 7, 2012).  This study was conducted among Danish cancer patients shows that patients taking statins have a lower risk of premature death from cancer.  Their risk of death from cancer was reduced by 15 percent.  This risk reduction is seemingly very modest, but traditional chemotherapy reduces the risk of dying only by a similar 15 percent.  

It is thought that the statins work against critical cellular functions that control tumor initiation, tumor growth and metastatic cancer spread.

It is estimated that 15 million Americans are taking statins for control of increased cholesterol levels in order to prevent heart disease and strokes.  During the recent years there has been a continuous trend in reduction of cancer because of early detection (like colonoscopies and mammograms) and cancer prevention secondary to reduction in cigarettes smoking.  

I find it tempting to speculate that the increasing use of statins has indirectly contributed to the gradual reduction in cancer mortality and the slow rise in the population’s average life span.

Should you be taking a statin medication?   Ask your medical health practitioner this question.

© 2012 Mandy Lender MD

www.karkinosfarm.com

Friday, March 30, 2012

ATTRACTING HEALTH

Team-work in the management of cancer patients is imperative.  The team will consist of the patient, a close relative, the physician oncologist, a nurse oncologist and possibly a social worker, and a pastor.  The patient is a member of the team.

In the Spring 2012 issue of the magazine CURE, Cancer Updates, Research & Education, the oncology nurse, Kimberly Stump-Sutliff is quoted:


“While this can be a frustrating process, Stump-Sutliff adds that when patients and doctors work together, they can usually find a viable solution.  A good healthcare provider will keep exploring alternatives to find something that works.  The goal is to ease treatment side effects without causing more problems.”

Ms. Stump-Sutliff is the associate medical editor for the American Cancer Society.  

In this quote she points out three essential elements required to attract health or cure.  The Team - a master-mind alliance; the Goal - the desired outcome; and exploring alternatives - summoning the required components to manifest a cure.



Not surprisingly these are three Key Concepts of the Law of Attraction.  


© 2012 Mandy Lender MD






Tuesday, March 27, 2012